Israel Englander Cytek Biosciences, Inc. Transaction History

Millennium Management LLC

$192 Billion
Q2 2025

A detailed history of Israel Englander (Millennium Management LLC) transactions in Cytek Biosciences, Inc. stock. As of the latest transaction made, Millennium Management LLC holds 924,772 shares of CTKB stock, worth $3.73 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

924,772

Previous 495,437 86.66%

Holding current value

$3.73 Million

Previous $1.99 Million 58.31%

% of portfolio

0.0%

Previous 0.0%

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	BUY	$2.42 - $3.99 $1.04 Million - $1.71 Million	429,335 Added 86.66%	924,772 $3.14 Million
Q1 2025 May 15, 2025	SELL	$4.0 - $7.26 $1.23 Million - $2.24 Million	-308,486 Reduced 38.37%	495,437 $1.99 Million
Q4 2024 Feb 14, 2025	BUY	$4.7 - $7.4 $2.88 Million - $4.54 Million	613,314 Added 321.77%	803,923 $5.22 Million
Q3 2024 Nov 14, 2024	SELL	$4.73 - $6.73 $3.58 Million - $5.09 Million	-755,881 Reduced 79.86%	190,609 $1.06 Million
Q2 2024 Aug 14, 2024	BUY	$5.3 - $6.91 $4.88 Million - $6.36 Million	919,845 Added 3452.22%	946,490 $5.28 Million
Q1 2024 May 15, 2024	BUY	$6.29 - $9.15 $167,597 - $243,801	26,645 New	26,645 $178,000
Q2 2023 Aug 14, 2023	SELL	$6.69 - $11.99 $2.49 Million - $4.46 Million	-372,172 Reduced 39.09%	580,003 $4.95 Million
Q1 2023 May 15, 2023	BUY	$8.44 - $13.47 $6.9 Million - $11 Million	817,445 Added 606.73%	952,175 $8.75 Million
Q4 2022 Feb 14, 2023	SELL	$9.71 - $15.86 $2.66 Million - $4.34 Million	-273,729 Reduced 67.02%	134,730 $1.38 Million
Q3 2022 Nov 14, 2022	SELL	$10.96 - $15.45 $5.41 Million - $7.63 Million	-494,023 Reduced 54.74%	408,459 $6.01 Million

Others Institutions Holding CTKB

# of Institutions

153

Shares Held

73.1M

Call Options Held

Put Options Held

View Full List

About Cytek Biosciences, Inc.

Ticker CTKB
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 134,627,008
Market Cap $543M
Description
Cytek Biosciences, Inc., a cell analysis solutions company, provides cell analysis tools that facilitates scientific advances in biomedical research and clinical applications. It offers aurora and northern lights systems, which are spectrum flow cytometers that delivers cell analysis by utilizing the fluorescence signatures from multiple lasers ...

More about CTKB

Track Israel Englander's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Account